Balance Sheet for Actinium Pharmaceuticals Inc. (Delaware) (ATNM)

$ 0.5617 R     -0.0283 (-4.80%) Volume: 14.17m 12:38 PM EDT 5-Aug-2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 9,254 13,673 17,400 20,519 25,643
Restrictable Cash 48 40 - 35 35
Marketable Securities - - - - -
Accounts Receivable - - - - -
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables - - - - -
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 786 616 439 1,836 803
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 10,088 14,330 17,839 22,390 26,481
Land and Improvements - - - - -
Buildings and Improvement - - - - -
Machinery, Furniture and Equipment 351 385 273 259 199
Construction in Progress - - - - -
Fixed Assets, Other 1,028 - - - -
Fixed Assets, Total 1,379 385 273 259 199
Gross Fixed Assets 1,379 385 273 259 199
Accumulated Depreciation (237) (266) (216) (170) (93)
Net Fixed Assets 1,142 119 57 89 106
Intangibles - - - - -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 391 391 391 - -
Total Non-Current Assets 1,583 560 498 138 106
Total Assets 11,670 14,889 18,337 22,529 26,588
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 4,598 5,814 4,650 4,220 1,499
Short Term Debt 365 - - 268 -
Notes Payable 381 249 - - 266
Accrued Expenses - - - - -
Accrued Liabilities - - - - -
Deferred Revenues - - - - -
Current Deferred Income Taxes - - - - -
Other Current Liabilities - - 16 33 2,849
Total Current Liabilities 5,344 6,063 4,666 4,521 4,614
Long Term Debt N/A N/A N/A - -
Deferred Income Tax - - - - -
Other Non-Current Liabilities - - - - -
Minority Interest - - - - -
Capital Lease Obligations 682 13 - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 682 13 - - -
Total Liabilities 6,026 6,077 4,666 4,521 4,614
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 5,644 8,813 13,671 18,008 21,974
Common Par 165 116 80 56 44
Additional Paid in Capital 214,237 195,554 176,744 154,504 134,160
Cumulative Translation Adjustments - - - - -
Retained Earnings (208,758) (186,857) (163,153) (136,552) (112,230)
Treasury Stock - - - - -
Other Equity Adjustments - - - - -
Total Capitalization 5,644 8,813 13,671 18,008 21,974
Total Equity 5,644 8,813 13,671 18,008 21,974
Total Liabilities & Shareholder's Equity 11,670 14,889 18,337 22,529 26,588
Cash Flow (21,899) (23,654) (26,601) (24,322) (21,025)
Working Capital 4,744 8,266 13,173 17,870 21,868
Free Cash Flow (21,525) (20,667) (21,578) (20,849) (18,592)
Invested Capital 5,644 8,813 13,671 18,008 21,974
Shares Outstanding - Common Class Only 164,701 115,703 80,072 55,802 44,067
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 164,701 115,703 80,072 55,802 44,067
Total Common Shares Outstanding 164,701 115,703 80,072 55,802 44,067
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 149,272 106,042 66,746 48,463 38,158
Diluted Weighted Shares Outstanding 149,272 106,042 66,746 48,463 38,158